* Galapagos to discover small molecule candidate drugs for pre-clinical development * Upfront fee, milestones on pre-clinical and clinical development of small molecule candidates, plus royalties on worldwide sales Click here to access the live audio ...
Read more...
Why in the heck did the world's chief food problem shift from malnutrition to obesity? That's the question Barry Popkin, director of the University of North Carolina's Inter-Disciplinary Obesity Center, explores in his new book, The World Is Fat ...
Read more...
(RTTNews) - Galapagos NV (GLPYY.PK: News ) announced that it has entered into a multi-year global strategic alliance with Merck & Co. Inc. to develop potential new therapies in obesity and diabetes. Under the terms of the agreement, Galapagos will ...
Read more...
NASHVILLE, Tenn., Jan. 7 /PRNewswire/ -- HealthLeaders-InterStudy, a leading provider of managed care market intelligence, reports that with the number of people diagnosed with diabetes in the United States doubling over the past 15 years, insurers ...
Read more...
Five things Apple needs to do at Macworld Expert: Microsoft made $1.5B on 'Vista Capable' campaign CES: Lenovo, touting thin PCs, takes second stab at consumer market Windows market share dives again as Mac nears 10% Back to the future: Vinyl record ...
Read more...
CAMBRIDGE, Mass. - (Business Wire) Alkermes, Inc. (NASDAQ: ALKS) today announced that its partner, Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD), has initiated a phase 1 study of a four-week long-acting injectable ...
Read more...
New study published in the Journal of Nutrition Education and Behavior Philadelphia, PA – As children transition from preschool-age to school-age, they may develop eating habits and leisure-time patterns that may not meet current recommendations ...
Read more...